|  Help  |  About  |  Contact Us

Publication : Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis.

First Author  Ghosh S Year  2010
Journal  Hepat Med Volume  2010
Issue  2 Pages  69-78
PubMed ID  21949477 Mgi Jnum  J:285507
Mgi Id  MGI:6400487 Doi  10.2147/HMER.S8902
Citation  Ghosh S, et al. (2010) Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. Hepat Med 2010(2):69-78
abstractText  Transgenic liver-specific inactivation of the carcinoembryonic antigen-related cell adhesion molecule (CEACAM1) impairs hepatic insulin clearance and causes hyperinsuline-mia, insulin resistance, elevation in hepatic and serum triglyceride levels, and visceral obesity. It also predisposes to nonalchoholic steatohepatitis (NASH) in response to a high-fat diet. To discern whether this phenotype reflects a physiological function of CEACAM1 rather than the effect of the dominant-negative transgene, we investigated whether Ceacam1 (gene encoding CEACAM1 protein) null mice with impaired insulin clearance also develop a NASH-like phenotype on a prolonged high-fat diet. Three-month-old male null and wild-type mice were fed a high-fat diet for 3 months and their NASH phenotype was examined. While high-fat feeding elevated hepatic triglyceride content in both strains of mice, it exacerbated macrosteatosis and caused NASH-characteristic fibrogenic changes and inflammatory responses more intensely in the null mouse. This demonstrates that CEACAM1-dependent insulin clearance pathways are linked with NASH pathogenesis.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

3 Bio Entities

Trail: Publication

0 Expression